Ypsomed
Olga Gusyatiner is an accomplished Clinical Research & Evaluation Manager (Associate Director) at Ypsomed AG, with experience in the medical device and pharmaceutical sectors. Previously, Olga served as a Clinical Evaluation Associate at Straumann Group, where responsibilities included medical writing for clinical evaluation plans and reports. A significant portion of Olga's career includes a role as a Research Fellow at CHUV | Lausanne University Hospital, leading a pre-clinical project and managing a brain tumor biobank. Olga holds a PhD in Cancer and Immunology from the University of Lausanne, complemented by a Diploma of Advanced Studies in Management of Clinical Trials from the University of Geneva, and a Master of Science in Biochemistry from the University of Oulu. Additional academic and professional background includes significant research contributions and roles in various esteemed institutions, strengthening Olga's expertise in clinical research and medical writing.
This person is not in any teams
Ypsomed
4 followers
Ypsomed Holding AG is a Switzerland-based holding company engaged in the manufacture of injection pens for pharmaceutical and biotech companies. The Company develops and manufactures injection systems for custom-made self-administration, and markets pen needles for the treatment of diabetes, growth disorders or infertility, as well as therapeutic areas. The Company operates two business segments: Injection Systems and Diabetes Care. In the Injection Systems segment, the Company's YDS Ypsomed Delivery Systems offer a range of ready-to-use injection systems for pharmaceutical and biotech companies to administer of drugs or to develop and manufacture them in line with customer requirements. The Diabetes Care segment markets products such as pen needles or insulin pump to diabetics, doctors and health insurance providers. The Company operates its production sites in Burgdorf, Solothurn, Grenchen and Tabor, and sales and distribution network across Europe.